Scopus h-index:28
- Home
- Profiles
Mount Sinai DoctorsGopi Patel, MD
Infectious Disease
No Patient Experience Ratings
- About Me
- Education & Certifications
- Awards
- Insurance
- Publications
- Industry Relationships
About Me
Dr. Patel specializes in the treatment of infections in immune-compromised patients like those who anticipate or should undergo solid organ or hematopoietic stem cell transplantation. She is also the medical director of the Mount Sinai Antimicrobial stewardship program where there is an emphasis placed on education of medical staff on the appropriate use of antimicrobials, cost-effectiveness and evidence-based management of infections.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Dr. Patel specializes in the treatment of infections in immune-compromised patients like those who anticipate or should undergo solid organ or hematopoietic stem cell transplantation. She is also the medical director of the Mount Sinai Antimicrobial stewardship program where there is an emphasis placed on education of medical staff on the appropriate use of antimicrobials, cost-effectiveness and evidence-based management of infections.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Dr. Patel specializes in the treatment of infections in immune-compromised patients like those who anticipate or should undergo solid organ or hematopoietic stem cell transplantation. She is also the medical director of the Mount Sinai Antimicrobial stewardship program where there is an emphasis placed on education of medical staff on the appropriate use of antimicrobials, cost-effectiveness and evidence-based management of infections.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Dr. Patel's research interests include healthcare-associated infections, multi-drug resistant bacterial infections and infections in the solid organ transplantation.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Education
MD, Albert Einstein College of Medicine
MS, The Mount Sinai School of Medicine
Internship, Internal Medicine
The Mount Sinai Hospital
Residency, Internal Medicine
The Mount Sinai Hospital
Fellowship, Infectious Diseases
The Mount Sinai Hospital
Certifications
Infectious Disease
American Board of Internal Medicine
Awards
2009
SHEA Barry Farr Award
2008
Annual Fellow's Award for Research
Infectious Diseases Society of New York
2007
Trainee Grant
Advancing Clinical Excellence in Medicine
2007
Research Day Honoree
The Mount Sinai School of Medicine Department of Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Article:55
Review Article:6
Comment/Debate:2
Letter:4
Editorial:1
Chapter:2
Recent Artifacts
- Everybody nose: molecular and clinical characteristics of nasal colonization during active methicillin-resistant Staphylococcus aureus bloodstream infection
- Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents
- Correlation between Identification of b-Lactamase Resistance Genes and Antimicrobial Susceptibility Profiles in Gram-Negative Bacteria: a Laboratory Data Analysis
- White paper on antimicrobial stewardship in solid organ transplant recipients
- Taking off the gown: Impact of discontinuing contact precautions for extended-spectrum β-lactamase (ESBL)-producing organisms
- Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic
- Overcoming challenges to removing inappropriate penicillin allergy labels: A quality improvement report
- A COVID-19 Test Triage Tool, Predicting Negative Results and Reducing the Testing Burden on Healthcare Systems During a Pandemic
- Adapting a vascular access service (VAS) to meet the needs of the COVID-19 pandemic
- Demographic Characteristics of Adults with IgG Antibodies to Prior Symptomatic SARS-CoV-2 Infection
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Patel did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.